Status: current, Defined. Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3302992018 | Obinutuzumab (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3302993011 | Obinutuzumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3644590010 | Product containing obinutuzumab | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3644591014 | Product containing obinutuzumab (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3669273011 | Obinutuzumab product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3715971012 | Obinutuzumab-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Obinutuzumab-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Obinutuzumab-containing product | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Obinutuzumab-containing product | Is a | Monoclonal antibody antineoplastic agent | true | Inferred relationship | Some | ||
| Obinutuzumab-containing product | Is a | Pharmaceutical / biologic product | false | Inferred relationship | Some | ||
| Obinutuzumab-containing product | Has active ingredient | Obinutuzumab | true | Inferred relationship | Some | 1 | |
| Obinutuzumab-containing product | Is a | Monoclonal antibody-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Obinutuzumab only product | Is a | True | Obinutuzumab-containing product | Inferred relationship | Some | |
| Obinutuzumab-containing product in parenteral dose form | Is a | True | Obinutuzumab-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR